创胜集团-B(06628)拟折让约18.76%配售1440万股 净筹约5934万港元

Core Viewpoint - The company plans to place 14.4 million shares at a price of HKD 4.33 per share, representing an approximate discount of 18.76% from the closing price on September 9 [1] Fundraising Details - The total expected proceeds from the placement are approximately HKD 62.35 million, with net proceeds estimated at around HKD 59.34 million [1] - The net proceeds will be allocated as follows: - 40% for clinical development of pipeline assets TST001 and TST002 - 30% to advance promising preclinical pipeline assets with near-term licensing potential, including TST801, TST013, and TST786 - 30% for working capital and general purposes to enhance financial stability, including general business operations and development [1]